companydata.dkcompanydata.dk

ABBLO PHARMA ApS: Financial statements 2018

CVR: 34080534

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 145,533 and a net result of DKK 12,115 compared with DKK -84,087 the year before. That is an increase of 21.6% compared with the year before. Equity in the 2018 report amounted to DKK -1,228,738. The company had 1 employee in the financial year.

Gross Profit
DKK 145,533
Profit/Loss
DKK 12,115
Equity
DKK -1,228,738
Total Assets
DKK 576,297
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-146 t.12 t.-1.2 mio.1
2017-120 t.-84 t.-1.2 mio.1
2016--217 t.-380 t.-1.2 mio.1
2014--126 t.2 mio.-215 t.-
2013--12 t.-2.7 mio.-2.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

ABBLO PHARMA ApS: The 2017 annual report is outMar 23, 2018

ABBLO PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 119,645, and the net result was DKK -84,087.

About ABBLO PHARMA ApS

ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.

Source: annual report 2025, Danish Business Authority